Azelis Group NV (FRA:2R7)

Blueprint Medicines Statistics

Total Valuation

Azelis Group NV has a market cap or net worth of EUR 3.22 billion. The enterprise value is 4.85 billion.

Market Cap	3.22B
Enterprise Value	4.85B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	Jun 27, 2025

Share Statistics

Current Share Class	243.45M
Shares Outstanding	n/a
Shares Change (YoY)	+0.49%
Shares Change (QoQ)	+0.71%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	175.80M

Valuation Ratios

The trailing PE ratio is 18.98 and the forward PE ratio is 14.43.

PE Ratio	18.98
Forward PE	14.43
PS Ratio	0.76
PB Ratio	1.20
P/TBV Ratio	n/a
P/FCF Ratio	10.84
P/OCF Ratio	9.94
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.12, with an EV/FCF ratio of 16.34.

EV / Earnings	28.63
EV / Sales	1.15
EV / EBITDA	10.12
EV / EBIT	13.28
EV / FCF	16.34

Financial Position

The company has a current ratio of 1.68, with a Debt / Equity ratio of 0.77.

Current Ratio	1.68
Quick Ratio	1.05
Debt / Equity	0.77
Debt / EBITDA	4.31
Debt / FCF	6.96
Interest Coverage	3.45

Financial Efficiency

Return on equity (ROE) is 6.41% and return on invested capital (ROIC) is 4.90%.

Return on Equity (ROE)	6.41%
Return on Assets (ROA)	3.99%
Return on Invested Capital (ROIC)	4.90%
Return on Capital Employed (ROCE)	7.88%
Revenue Per Employee	978,310
Profits Per Employee	39,208
Employee Count	4,321
Asset Turnover	0.74
Inventory Turnover	5.17

Taxes

In the past 12 months, Azelis Group NV has paid 59.97 million in taxes.

Income Tax	59.97M
Effective Tax Rate	25.54%

Stock Price Statistics

The stock price has decreased by -22.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-22.53%
50-Day Moving Average	13.91
200-Day Moving Average	16.87
Relative Strength Index (RSI)	39.37
Average Volume (20 Days)	1,120

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Azelis Group NV had revenue of EUR 4.23 billion and earned 169.42 million in profits. Earnings per share was 0.69.

Revenue	4.23B
Gross Profit	996.53M
Operating Income	365.36M
Pretax Income	234.81M
Net Income	169.42M
EBITDA	447.03M
EBIT	365.36M
Earnings Per Share (EPS)	0.69

Balance Sheet

The company has 452.29 million in cash and 2.07 billion in debt, giving a net cash position of -1.61 billion.

Cash & Cash Equivalents	452.29M
Total Debt	2.07B
Net Cash	-1.61B
Net Cash Per Share	n/a
Equity (Book Value)	2.68B
Book Value Per Share	10.81
Working Capital	694.90M

Cash Flow

In the last 12 months, operating cash flow was 323.63 million and capital expenditures -26.83 million, giving a free cash flow of 296.80 million.

Operating Cash Flow	323.63M
Capital Expenditures	-26.83M
Free Cash Flow	296.80M
FCF Per Share	n/a

Margins

Gross margin is 23.57%, with operating and profit margins of 8.64% and 4.01%.

Gross Margin	23.57%
Operating Margin	8.64%
Pretax Margin	5.55%
Profit Margin	4.01%
EBITDA Margin	10.57%
EBIT Margin	8.64%
FCF Margin	7.02%

Dividends & Yields

This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 1.16%.

Dividend Per Share	0.16
Dividend Yield	1.16%
Dividend Growth (YoY)	3.01%
Years of Dividend Growth	n/a
Payout Ratio	31.47%
Buyback Yield	-0.49%
Shareholder Yield	0.68%
Earnings Yield	5.27%
FCF Yield	9.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Azelis Group NV has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	7